
Sign up to save your podcasts
Or


Alex is the Deputy Director of Health Innovation West of England (previously known as West of England Academic Health Science Network (AHSN)).
Alex and I discuss the change from AHSN to Health Innovation Organisation, part of the 15-strong network of Innovation organisations that cover the UK in the Health Innovation Network.
The help and support offered to innovators includes networking and introductions, support with implementation and funding.
The Innovation Network can be contacted through the NHS Innovation Service portal www.innovation.nhs.uk
Do you need a clinical trial?
Nicola and Elizabeth are co-founders and directors of Afortiori Developments, a Contract Research Organisation (CRO), that has worked with companies of all sizes but is particularly familiar with SMEs and new market entrants.
We discuss what needs to be considered when planning a clinical trial, which units and clinicians to work with, and the differing levels of evidence that may be required.
In a break from the norm, this episode is a discussion between Kate and mother and son, Laura, and Elias.
We discuss ADHD, podcasts, dementia, and how to go about creating effective technology. Also, what happens when your great idea doesn’t quite make it?
Talking from the perspective of the problem rather than the solution.
Vicki Munro is a very experienced Health Economist and Senior Associate at Pym’s Consultancy.
We discuss the role of Health Economics in bringing a new product to market and the vital part Health Economics plays in NICE Approval.
Thought passing regulatory hurdles was enough? Think again, what does your Cost Per QALY look like?
The Chief Executive of Gain (Guillan Barré and Associated Neuropathies), a national charity, discusses the reality of being a patient living with a neurological condition, and how the charity works with companies trying to improve patient lives.
In previous episodes, we have discussed the importance of patient and public involvement. In this episode, you find out what is involved.
This episode explores commissioning new services from the perspective of those involved in writing the invitation to tender.
Rachel was a key member of the team at Midlands Partnership NHS Foundation Trust which commissioned the Mindler Sandbox to provide a digital mental health and wellbeing service (listen to Tim Hamer’s interview to hear about this being their first NHS contract).
How was this invitation to tender written, and how was the final decision made?
Craig is a Partner and IP Attorney at HGF.
As our “go-to guy” for Intellectual Property questions and solutions, Craig specialises in creating an IP plan to keep costs within budget whilst making a positive contribution to the company's commercial strategy and long-term planning.
What is IP? What value does it represent for the company? When do you need to start planning your approach to IP?
In this episode, Dr Alex Graham, Co-Founder of Abed Graham Group, talks about compliance.
This takes us on a whistle-stop tour of DTAC, DCB0129, DPIAs, GDPR and the NHS Data Security Tool Kit. Does your product pose a threat to NHS data security?
What potential risks does it pose to patients, staff or data if used incorrectly, or if it fails to work properly? How and why to comply with these standards – and the competitive edge they could give you.
Achala is the Founder and Managing Director of Entec Health, a MedTech company working in wound care.
The company was founded in 2012. This is a success story about creating a sustainable business through building relationships with clinicians, listening to their needs, helping clinicians to help patients understand their treatment, and the value of following advice to improve their outcomes.
Join us in this fascinating talk about wound management medtech!
Jackie Leach Scully is a Professor of Bioethics at the University of New South Wales. We discuss PPIE – Patient and Public Involvement and Engagement, a mandatory requirement for any project which receives grant funding.
A hurdle to overcome, or a vital element of product development and market entry?